Bank of Montreal’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,473
| Closed | -$1.06M | – | 5103 |
|
|
2019
Q4 | $1.06M | Buy |
12,473
+289
| +2% | +$19.3K | ﹤0.01% | 2236 |
|
|
2019
Q3 | $609K | Buy |
12,184
+2,561
| +27% | +$102K | ﹤0.01% | 2301 |
|
|
2019
Q2 | $350K | Buy |
9,623
+6,067
| +171% | +$198K | ﹤0.01% | 2634 |
|
|
2019
Q1 | $99K | Buy |
3,556
+417
| +13% | +$9.83K | ﹤0.01% | 3064 |
|
|
2018
Q4 | $59K | Buy |
3,139
+760
| +32% | +$17.7K | ﹤0.01% | 3217 |
|
|
2018
Q3 | $71K | Sell |
2,379
-15
| -0.6% | -$565 | ﹤0.01% | 3245 |
|
|
2018
Q2 | $88K | Buy |
2,394
+459
| +24% | +$14.9K | ﹤0.01% | 3189 |
|
|
2018
Q1 | $64K | Buy |
1,935
+38
| +2% | +$1.19K | ﹤0.01% | 3138 |
|
|
2017
Q4 | $52K | Sell |
1,897
-1,289
| -40% | -$39.7K | ﹤0.01% | 3258 |
|
|
2017
Q3 | $118K | Buy |
3,186
+72
| +2% | +$2.65K | ﹤0.01% | 2919 |
|
|
2017
Q2 | $119K | Sell |
3,114
-174
| -5% | -$7.75K | ﹤0.01% | 2913 |
|
|
2017
Q1 | $161K | Sell |
3,288
-42,635
| -93% | -$1.94M | ﹤0.01% | 2591 |
|
|
2016
Q4 | $1.61M | Sell |
45,923
-149,114
| -76% | -$5.29M | ﹤0.01% | 1675 |
|
|
2016
Q3 | $7.36M | Buy |
195,037
+8,094
| +4% | +$305K | 0.01% | 944 |
|
|
2016
Q2 | $6.29M | Sell |
186,943
-56,186
| -23% | -$1.98M | 0.01% | 1001 |
|
|
2016
Q1 | $7.72M | Sell |
243,129
-54,363
| -18% | -$1.78M | 0.01% | 842 |
|
|
2015
Q4 | $11.1M | Buy |
297,492
+67,616
| +29% | +$2.56M | 0.01% | 682 |
|
|
2015
Q3 | $8.73M | Buy |
229,876
+44,851
| +24% | +$1.57M | 0.01% | 761 |
|
|
2015
Q2 | $5.29M | Sell |
185,025
-54,908
| -23% | -$1.53M | 0.01% | 1039 |
|
|
2015
Q1 | $6.72M | Sell |
239,933
-677
| -0.3% | -$19K | 0.01% | 947 |
|
|
2014
Q4 | $6.66M | Buy |
240,610
+23,924
| +11% | +$593K | 0.01% | 934 |
|
|
2014
Q3 | $4.84M | Sell |
216,686
-119,203
| -35% | -$3.03M | 0.01% | 1100 |
|
|
2014
Q2 | $9.76M | Sell |
335,889
-61,681
| -16% | -$1.65M | 0.01% | 815 |
|
|
2014
Q1 | $11.3M | Buy |
397,570
+2,524
| +0.6% | +$83.5K | 0.01% | 614 |
|
|
2013
Q4 | $15.3M | Buy |
395,046
+82,839
| +27% | +$2.96M | 0.02% | 457 |
|
|
2013
Q3 | $10.5M | Buy |
312,207
+287,333
| +1,155% | +$9.15M | 0.02% | 510 |
|
|
2013
Q2 | $765K | Buy |
+24,874
| New | +$832K | ﹤0.01% | 1524 |
|
Other funds holding MDCO
Bank of Montreal's MDCO Position: Q1 2020 in Review
Bank of Montreal sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 12,473 shares — an estimated $1.06M sold.
Bank of Montreal first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $15.3M in Q4 2013. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Bank of Montreal reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Bank of Montreal sold 12,473 Medicines Co shares in Q1 2020, an estimated $1.06M.
- Bank of Montreal first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Bank of Montreal's Medicines Co position peaked at $15.3M in Q4 2013.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.